We also confirmed the recent observation that CTLA-4 expression in peripheral blood CLL cells negatively correlates with disease progression, suggesting its clinical relevance as a prognostic marker. This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.